J&J’s $21.3B acquisition of Synthes to go through EU antitrust review by March 2012

By

   
 
 
EU opens probe into Johnson & Johnson's Synthes buy (press release)
-- EU launches investigation due to antitrust concerns
-- To make a final decision on acquisition in March
BRUSSELS -(MarketWatch)- U.S. pharmaceutical company Johnson & Johnson's JNJ -0.34% $21.3 billion bid for Synthes Inc. has been referred to a second-phase in-depth probe by the European Union's antitrust unit, giving Brussels authorities until March to decide on the case.
In a statement issued early Friday, the European Commission said it has concerns that the proposed deal would limit competitio...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.